IBD and experimental intestinal inflammation models including dextran sulfate sodium (DSS), trinitrobenzene sulfonic acid (TNBS)-induced colitis and IL-10 knockout mice are characterized by NF-κB activation and increased expression of pro-inflammatory NF-κB target genes [25,26]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.